Interplay between scatter factor receptors and B plexins controls invasive growth
- PMID: 15184888
- DOI: 10.1038/sj.onc.1207650
Interplay between scatter factor receptors and B plexins controls invasive growth
Abstract
Met and Ron tyrosine kinases are members of the Scatter Factor Receptor family. Met is the receptor for hepatocyte growth factor while Ron is that for macrophage stimulating protein. On ligand stimulation, activation of these receptors induces 'invasive growth', a complex biological response involved in tissue morphogenesis and, when deregulated, in tumor progression and metastasis. Scatter Factor Receptors share structural homology with Plexins, transmembrane receptors for Semaphorins, a family of ligands originally identified as axon guidance molecules. A physical and functional association between Met and Plexin B1, the prototype of class B Plexin subfamily, has been previously demonstrated. Here, we show that both Met and Ron receptors can interact with each of the three members of class B Plexins, even in the absence of their ligands and that Plexin B1 ligand, Sema 4D, can induce activation of Met and Ron receptors, promoting an invasive response. Furthermore, in some human neoplastic cell lines Plexin B1 is overexpressed, constitutively tyrosine phosphorylated, and associated with Scatter Factor Receptors. These data extend the crosstalk previously described between Met and Plexin B1 to the entire families of Scatter Factor Receptors and class B Plexins and show that interaction with multiple upstream activators can finely tune the invasive growth process both in physiological conditions and in tumor growth and metastatization.
Similar articles
-
Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B.Cancer Res. 2004 Aug 1;64(15):5212-24. doi: 10.1158/0008-5472.CAN-04-0126. Cancer Res. 2004. PMID: 15289326
-
Plexins, semaphorins, and scatter factor receptors: a common root for cell guidance signals?IUBMB Life. 1999 Nov;48(5):477-82. doi: 10.1080/713803563. IUBMB Life. 1999. PMID: 10637762 Review.
-
Semaphorin-4D (Sema-4D), the Plexin-B1 ligand, is involved in mouse ovary follicular development.Reprod Biol Endocrinol. 2007 Mar 21;5:12. doi: 10.1186/1477-7827-5-12. Reprod Biol Endocrinol. 2007. PMID: 17376242 Free PMC article.
-
The semaphorin receptor plexin-B1 specifically interacts with active Rac in a ligand-dependent manner.Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12457-62. doi: 10.1073/pnas.220421797. Proc Natl Acad Sci U S A. 2000. PMID: 11035813 Free PMC article.
-
Cancer therapy: can the challenge be MET?Trends Mol Med. 2005 Jun;11(6):284-92. doi: 10.1016/j.molmed.2005.04.005. Trends Mol Med. 2005. PMID: 15949770 Review.
Cited by
-
The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further Studies.Molecules. 2019 Dec 4;24(24):4443. doi: 10.3390/molecules24244443. Molecules. 2019. PMID: 31817278 Free PMC article.
-
Semaphorin signaling in the development and function of the gonadotropin hormone-releasing hormone system.Front Endocrinol (Lausanne). 2013 Sep 23;4:133. doi: 10.3389/fendo.2013.00133. Front Endocrinol (Lausanne). 2013. PMID: 24065959 Free PMC article. Review.
-
Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.Adv Cancer Res. 2008;100:1-33. doi: 10.1016/S0065-230X(08)00001-8. Adv Cancer Res. 2008. PMID: 18620091 Free PMC article. Review.
-
Crystal structure of the Sema-PSI extracellular domain of human RON receptor tyrosine kinase.PLoS One. 2012;7(7):e41912. doi: 10.1371/journal.pone.0041912. Epub 2012 Jul 25. PLoS One. 2012. PMID: 22848655 Free PMC article.
-
c-MET as a potential therapeutic target and biomarker in cancer.Ther Adv Med Oncol. 2011 Nov;3(1 Suppl):S21-35. doi: 10.1177/1758834011422557. Ther Adv Med Oncol. 2011. PMID: 22128285 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
